Ray Fury
Executive Vice President, General Counsel and Corporate Secretary
Replay available
Rigel Pharmaceuticals, Inc. (RIGL) Q1 2025 Earnings Call
Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) Q1 2025 earnings conference call, held 2025-05-06. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Raul Rodriguez
President and Chief Executive Officer
Dave Santos
Chief Commercial Officer
Lisa Royker
Chief Medical Officer
Dean Shorno
Chief Financial Officer
Kalpit Patel
Analyst, B. Reilly Securities
Joe Panginus
Analyst, HC Wainwright
Farzeen Haque
Analyst, Jefferies
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Rigel Pharmaceuticals, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:05.156 Greetings and welcome to Rigel Pharmaceuticals financial conference call for 00:00:05.156 -- 00:00:07.857 the first quarter 2025. 00:00:08.379 -- 00:00:11.863 At this time all participants are in a listen only mode. 00:00:11.863 -- 00:00:15.667 A brief question and answer session will follow the formal presentation. 00:00:15.667 -- 00:00:19.711 If anyone should require operator assistance during the conference please press star 00:00:19.711 -- 00:00:25.777 zero on your telephone keypad. As a reminder this conference is being recorded. 00:00:25.777 -- 00:00:31.073 It is now my pleasure to introduce our first speaker Ray Fury, Rigel's 00:00:31.073 -- 00:00:35.558 Executive Vice President, General Counsel, and Corporate Secretary. 00:00:35.558 -- 00:00:38.779 Thank you, Mr. Fury. You may begin. 00:00:39.382 -- 00:00:44.828 Welcome to our first quarter 2025 financial results and business update conference call. 00:00:44.828 -- 00:00:49.914 The financial press release for the first quarter 2025 was issued a short while ago and 00:00:49.914 -- 00:00:55.320 can be viewed along with the slides for this presentation in the news and events section 00:00:55.320 -- 00:00:58.739 of our investor relations site on Rigel.com. 00:00:58.739 -- 00:01:03.105 As a reminder, during today's call, we may make forward-looking statements regarding 00:01:03.105 -- 00:01:08.552 our financial outlook and our plans and timing for regulatory and product development. 00:01:08.552 -- 00:01:13.219 These statements are subject to risks and uncertainties that may cause actual results 00:01:13.219 -- 00:01:18.305 to differ from those forecasted. A description of these risks can be found in our most 00:01:18.305 -- 00:01:23.472 recent annual report on Form 10-K for the...